MCK McKesson Corporation

Q4 2025 10-Q
Filed: Feb 4, 2026Period ending Dec 31, 2025
Consumer Staples
Wholesale-Drugs, Proprietaries & Druggists' SundriesSEC EDGAR

McKesson Corporation (MCK) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 4, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Management Discussion & Analysis

  • Revenue $106.2B Q2 FY26, up 11% YoY from $95.3B; $307.1B 9M FY26, up 15% YoY from $268.2B
  • Operating margin 1.81% Q2 FY26 vs ~1.52% Q2 FY25 estimated (1,916M profit on 106,158M revenue vs 1,448M on 95,294M)
+4 more insights

Risk Factors

  • New operational risk from Rite Aid bankruptcy impact: $29M net charge in provision for bad debts and vendor credits recorded in 3Q FY26
  • Most material update in restructuring charges: $146M in 9M FY26 vs $213M in 9M FY25, reflecting ongoing cost optimization initiatives
+3 more insights

Other McKesson Corporation Quarterly Reports

Get deeper insights on McKesson Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.